BioSpace News Archive

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, will report its second quarter 2020 operational and financial results on Thursday, August 6, 2020 after the U.S. financial markets close

Piramal Pharma Solutions, a leading contract development and manufacturing organization (CDMO), today announced that it is providing Bolt Biotherapeutics (Bolt) with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt’s ongoing Phase 1/2 clinical study in cancer patients.

- COVID-19 patients in Singapore are being monitored using Biofourmis’ cutting-edge wearable and artificial intelligence technology to accelerate disease surveillance and interventions - Biofourmis staff support clinicians and nurses to implement the program and provide 24/7 technical assistance to patients to increase adherence to monitoring program [29-July-2020]

Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced today that the Company intends to release its operational highlights and financial results for the quarter ended June 30, 2020 on Thursday, August 6, 2020,

Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced that it will report its financial results for the second quarter of 2020 together with a business update on Wednesday, August 5, 2020, after the close of the US market.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2020 on Wednesday, August 5, 2020, after the market closes.

Georgia Urology –the largest urology practice in the Southeast and the fifth largest of its kind in the country– announced Dan Fellner, formerly the company’s Director of Human Resources, as its new Chief Executive Officer.

Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company demonstrated 3D imaging capabilities using artificial intelligence (AI) on our Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT) device. *1 Kubota Vision completed a successful clinical study in

Contract Development and Manufacturing Organization further expands its commitment to climate protection